Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice.

Ko EJ, Lee Y, Lee YT, Jung YJ, Ngo VL, Kim MC, Kim KH, Wang BZ, Gewirtz AT, Kang SM.

Vaccine. 2019 Jun 6;37(26):3426-3434. doi: 10.1016/j.vaccine.2019.05.018. Epub 2019 May 14.

PMID:
31101421
2.

Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells.

Ko EJ, Lee YT, Kim KH, Jung YJ, Lee Y, Denning TL, Kang SM.

J Virol. 2016 Jul 11;90(15):6976-6988. doi: 10.1128/JVI.00339-16. Print 2016 Aug 1.

3.

Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine.

Kim KH, Kwon YM, Lee YT, Hwang HS, Kim MC, Ko EJ, Wang BZ, Quan FS, Kang SM.

Virology. 2018 Nov;524:172-181. doi: 10.1016/j.virol.2018.08.019. Epub 2018 Sep 7.

PMID:
30199754
4.

Roles of major histocompatibility complex class II in inducing protective immune responses to influenza vaccination.

O E, Lee YT, Ko EJ, Kim KH, Lee YN, Song JM, Kwon YM, Kim MC, Perez DR, Kang SM.

J Virol. 2014 Jul;88(14):7764-75. doi: 10.1128/JVI.00748-14. Epub 2014 Apr 23.

5.

Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.

Beljanski V, Chiang C, Kirchenbaum GA, Olagnier D, Bloom CE, Wong T, Haddad EK, Trautmann L, Ross TM, Hiscott J.

J Virol. 2015 Oct;89(20):10612-24. doi: 10.1128/JVI.01526-15. Epub 2015 Aug 12.

6.

Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.

Kim YJ, Kim KH, Ko EJ, Kim MC, Lee YN, Jung YJ, Lee YT, Kwon YM, Song JM, Kang SM.

J Virol. 2018 Sep 26;92(20). pii: e00969-18. doi: 10.1128/JVI.00969-18. Print 2018 Oct 15.

7.

Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection.

Wang BZ, Xu R, Quan FS, Kang SM, Wang L, Compans RW.

PLoS One. 2010 Nov 29;5(11):e13972. doi: 10.1371/journal.pone.0013972.

8.

Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.

Wang BZ, Quan FS, Kang SM, Bozja J, Skountzou I, Compans RW.

J Virol. 2008 Dec;82(23):11813-23. doi: 10.1128/JVI.01076-08. Epub 2008 Sep 10.

9.

Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice.

Ren Z, Zhao Y, Liu J, Ji X, Meng L, Wang T, Sun W, Zhang K, Sang X, Yu Z, Li Y, Feng N, Wang H, Yang S, Yang Z, Wang Z, Gao Y, Xia X.

Vaccine. 2018 Sep 25;36(40):5990-5998. doi: 10.1016/j.vaccine.2018.08.053. Epub 2018 Aug 30.

PMID:
30172635
10.

An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Khalil SM, Tonkin DR, Snead AT, Parks GD, Johnston RE, White LJ.

J Virol. 2014 Aug;88(16):9182-96. doi: 10.1128/JVI.00327-14. Epub 2014 Jun 4.

11.

Enhanced humoural and cellular immune responses to influenza H7N9 antigen HA1-2 fused with flagellin in chickens.

Song L, Xiong D, Hu M, Kang X, Pan Z, Jiao X.

BMC Vet Res. 2017 Jun 21;13(1):190. doi: 10.1186/s12917-017-1106-4.

12.

Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.

Kasturi SP, Kozlowski PA, Nakaya HI, Burger MC, Russo P, Pham M, Kovalenkov Y, Silveira ELV, Havenar-Daughton C, Burton SL, Kilgore KM, Johnson MJ, Nabi R, Legere T, Sher ZJ, Chen X, Amara RR, Hunter E, Bosinger SE, Spearman P, Crotty S, Villinger F, Derdeyn CA, Wrammert J, Pulendran B.

J Virol. 2017 Jan 31;91(4). pii: e01844-16. doi: 10.1128/JVI.01844-16. Print 2017 Feb 15.

13.

Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice.

Kim YJ, Lee YT, Kim MC, Lee YN, Kim KH, Ko EJ, Song JM, Kang SM.

Front Immunol. 2017 Dec 8;8:1730. doi: 10.3389/fimmu.2017.01730. eCollection 2017.

15.

Multi-subtype influenza virus-like particles incorporated with flagellin and granulocyte-macrophage colony-stimulating factor for vaccine design.

Liu WC, Liu YY, Chen TH, Liu CC, Jan JT, Wu SC.

Antiviral Res. 2016 Sep;133:110-8. doi: 10.1016/j.antiviral.2016.07.021. Epub 2016 Aug 1.

PMID:
27491439
16.

Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates.

Kim JR, Holbrook BC, Hayward SL, Blevins LK, Jorgensen MJ, Kock ND, De Paris K, D'Agostino RB Jr, Aycock ST, Mizel SB, Parks GD, Alexander-Miller MA.

J Virol. 2015 Jul;89(14):7291-303. doi: 10.1128/JVI.00549-15. Epub 2015 May 6.

17.

Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination.

Lee YN, Lee YT, Kim MC, Hwang HS, Lee JS, Kim KH, Kang SM.

Immunology. 2014 Oct;143(2):300-9. doi: 10.1111/imm.12310.

18.
19.

Evaluation of the Immunogenicity of a Potyvirus-Like Particle as an Adjuvant of a Synthetic Peptide.

Cárdenas-Vargas A, Elizondo-Quiroga D, Gutierrez-Ortega A, Charles-Niño C, Pedroza-Roldán C.

Viral Immunol. 2016 Dec;29(10):557-564. Epub 2016 Nov 11.

PMID:
27834623
20.

Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.

Song L, Xiong D, Hu M, Kang X, Pan Z, Jiao X.

PLoS One. 2016 Mar 1;11(3):e0150678. doi: 10.1371/journal.pone.0150678. eCollection 2016.

Supplemental Content

Support Center